Eska HCT Tablet 5/40/12.5 mg

Adult dose

This medication should be taken once daily with water, regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/20 mg combination therapy. - 5/40/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with amlodipine/olmesartan medoxomil 5/40 mg combination therapy.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established; hence, administration of this medication is not recommended.

This medication can cause serious harm to the fetus and neonate if taken during the second and third trimesters of pregnancy; therefore, use should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in individuals with known allergies to its components or similar medications, pregnant women, patients with severe hypotension, or those with severely impaired cardiac or renal function. Patients with reduced blood volume or body salt may experience hypotension symptoms when taking this medication for the first time, so they should be monitored closely, and appropriate action should be taken if symptoms occur. Patients with poor kidney function, renal transplant recipients, patients with liver insufficiency, and those with severe heart disease should exercise caution when using this medication. This medication has a strong blood pressure-lowering effect, so when used in conjunction with other antihypertensive medications or certain drugs, side effects or enhanced effects may occur; therefore, it is important to follow the physician's instructions closely. During treatment, electrolyte levels in the blood and kidney function should be checked regularly to ensure there are no abnormalities, and attention should be paid to electrolyte imbalances such as hypokalemia or hyperkalemia. This medication may cause symptoms such as dizziness or drowsiness, so caution should be exercised when driving or operating machinery during these times. The hydrochlorothiazide component may react sensitively to sunlight, so users should take care to use sunscreen and protect their skin while taking this medication. This medication is not recommended for children under 18 years of age, as its safety and efficacy have not been established. Elderly patients may have reduced kidney and liver function; therefore, they should start with a low dosage and be monitored closely. In case of overdose, severe hypotension or cardiac dysrhythmias may occur; patients experiencing symptoms should consult a healthcare professional immediately and receive appropriate treatment. This medication should be stored out of reach of children and kept in the original packaging, protected from direct sunlight and moisture.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or breathing difficulties, asthma attacks, respiratory abnormalities with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion of consciousness, visual disturbances, paralysis, decreased urine output

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, it should be kept at room temperature, between 1 and 30 degrees Celsius, avoiding locations that are too hot or too cold.

Appearance

Light yellow round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu × 3)